v3.26.1
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Deficit (Unaudited) - USD ($)
Total
Convertible Preferred Stock
Convertible Preferred Stock
Series E-1 And Series F Convertible Preferred Stock
Convertible Preferred Stock Held by Consolidated VIE
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   209,613,570   51,247,915        
Beginning balance at Dec. 31, 2024   $ 322,748,000   $ (2,381,000)        
Ending balance (in shares) at Mar. 31, 2025   209,613,570   51,247,915        
Ending balance at Mar. 31, 2025   $ 322,748,000   $ (2,381,000)        
Beginning balance (in shares) at Dec. 31, 2024         82,642,684      
Beginning balance at Dec. 31, 2024 $ (504,685,000)       $ 300,000 $ (23,417,000) $ 162,643,000 $ (644,211,000)
Beginning balance (in shares) at Dec. 31, 2024           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         127,206      
Exercise of vested stock options 7,000       $ 1,000   6,000  
Stock-based compensation expense 416,000           416,000  
Net income (loss) 50,375,000             50,375,000
Ending balance (in shares) at Mar. 31, 2025         82,769,890      
Ending balance at Mar. 31, 2025 (453,887,000)       $ 301,000 $ (23,417,000) 163,065,000 (593,836,000)
Ending balance (in shares) at Mar. 31, 2025           (5,177,235)    
Beginning balance (in shares) at Dec. 31, 2024   209,613,570   51,247,915        
Beginning balance at Dec. 31, 2024   $ 322,748,000   $ (2,381,000)        
Ending balance (in shares) at Jun. 30, 2025   209,613,570   51,247,915        
Ending balance at Jun. 30, 2025   $ 322,748,000   $ (2,381,000)        
Beginning balance (in shares) at Dec. 31, 2024         82,642,684      
Beginning balance at Dec. 31, 2024 (504,685,000)       $ 300,000 $ (23,417,000) 162,643,000 (644,211,000)
Beginning balance (in shares) at Dec. 31, 2024           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         318,106      
Exercise of vested stock options 17,000       $ 3,000   14,000  
Stock-based compensation expense 846,000           846,000  
Net income (loss) (7,352,000)             (7,352,000)
Ending balance (in shares) at Jun. 30, 2025         82,960,790      
Ending balance at Jun. 30, 2025 (511,174,000)       $ 303,000 $ (23,417,000) 163,503,000 (651,563,000)
Ending balance (in shares) at Jun. 30, 2025           (5,177,235)    
Beginning balance (in shares) at Mar. 31, 2025   209,613,570   51,247,915        
Beginning balance at Mar. 31, 2025   $ 322,748,000   $ (2,381,000)        
Ending balance (in shares) at Jun. 30, 2025   209,613,570   51,247,915        
Ending balance at Jun. 30, 2025   $ 322,748,000   $ (2,381,000)        
Beginning balance (in shares) at Mar. 31, 2025         82,769,890      
Beginning balance at Mar. 31, 2025 (453,887,000)       $ 301,000 $ (23,417,000) 163,065,000 (593,836,000)
Beginning balance (in shares) at Mar. 31, 2025           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         190,900      
Exercise of vested stock options 10,000       $ 2,000   8,000  
Stock-based compensation expense 430,000           430,000  
Net income (loss) (57,727,000)             (57,727,000)
Ending balance (in shares) at Jun. 30, 2025         82,960,790      
Ending balance at Jun. 30, 2025 $ (511,174,000)       $ 303,000 $ (23,417,000) 163,503,000 (651,563,000)
Ending balance (in shares) at Jun. 30, 2025           (5,177,235)    
Beginning balance (in shares) at Dec. 31, 2025 261,227,694 261,227,694   51,247,915        
Beginning balance at Dec. 31, 2025   $ 396,556,000   $ (2,381,000)        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13) (in shares)     77,378,045          
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13)     $ 81,770,000          
Ending balance (in shares) at Mar. 31, 2026   338,605,739   51,247,915        
Ending balance at Mar. 31, 2026   $ 478,326,000   $ (2,381,000)        
Beginning balance (in shares) at Dec. 31, 2025 78,202,775       83,380,010      
Beginning balance at Dec. 31, 2025 $ (538,783,000)       $ 307,000 $ (23,417,000) 164,240,000 (679,913,000)
Beginning balance (in shares) at Dec. 31, 2025           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         96,580      
Exercise of vested stock options 2,000           2,000  
Stock-based compensation expense 521,000           521,000  
Net income (loss) 64,651,000             64,651,000
Ending balance (in shares) at Mar. 31, 2026         83,476,590      
Ending balance at Mar. 31, 2026 $ (473,609,000)       $ 307,000 $ (23,417,000) 164,763,000 (615,262,000)
Ending balance (in shares) at Mar. 31, 2026           (5,177,235)    
Beginning balance (in shares) at Dec. 31, 2025 261,227,694 261,227,694   51,247,915        
Beginning balance at Dec. 31, 2025   $ 396,556,000   $ (2,381,000)        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13) (in shares)     161,045,853          
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13)     $ 172,967,000          
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) (in shares)       (113,560)        
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13)       $ (69,000)        
Return of Convertible Preferred Stock from investor (Note 13) (in shares)   (289,560)            
Return of Convertible Preferred Stock from investor (Note 13)   $ (152,000)            
Ending balance (in shares) at Jun. 30, 2026 421,983,987 421,983,987   51,361,475        
Ending balance at Jun. 30, 2026   $ 569,371,000   $ (2,450,000)        
Beginning balance (in shares) at Dec. 31, 2025 78,202,775       83,380,010      
Beginning balance at Dec. 31, 2025 $ (538,783,000)       $ 307,000 $ (23,417,000) 164,240,000 (679,913,000)
Beginning balance (in shares) at Dec. 31, 2025           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         1,229,353      
Exercise of vested stock options 33,000       $ 11,000   22,000  
Cashless exercise of common stock warrants (Note 13) (in shares)         503,821      
Cashless exercise of common stock warrants (Note 13) 0       $ 5,000   (5,000)  
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) (in shares)         (244,130)      
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) 69,000           (133,000) 202,000
Return of Convertible Preferred Stock from investor (Note 13) 152,000             152,000
Stock-based compensation expense 899,000           899,000  
Net income (loss) $ 71,032,000             71,032,000
Ending balance (in shares) at Jun. 30, 2026 79,935,949       84,869,054      
Ending balance at Jun. 30, 2026 $ (466,598,000)       $ 323,000 $ (23,417,000) 165,023,000 (608,527,000)
Ending balance (in shares) at Jun. 30, 2026           (5,177,235)    
Beginning balance (in shares) at Mar. 31, 2026   338,605,739   51,247,915        
Beginning balance at Mar. 31, 2026   $ 478,326,000   $ (2,381,000)        
Increase (Decrease) in Temporary Equity [Roll Forward]                
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13) (in shares)     83,667,808          
Exercise of Series E-1 and F convertible preferred stock warrants (Note 13)     $ 91,197,000          
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) (in shares)       (113,560)        
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13)       $ (69,000)        
Return of Convertible Preferred Stock from investor (Note 13) (in shares)   (289,560)            
Return of Convertible Preferred Stock from investor (Note 13)   $ (152,000)            
Ending balance (in shares) at Jun. 30, 2026 421,983,987 421,983,987   51,361,475        
Ending balance at Jun. 30, 2026   $ 569,371,000   $ (2,450,000)        
Beginning balance (in shares) at Mar. 31, 2026         83,476,590      
Beginning balance at Mar. 31, 2026 $ (473,609,000)       $ 307,000 $ (23,417,000) 164,763,000 (615,262,000)
Beginning balance (in shares) at Mar. 31, 2026           (5,177,235)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Exercise of vested stock options (in shares)         1,132,773      
Exercise of vested stock options 31,000       $ 11,000   20,000  
Cashless exercise of common stock warrants (Note 13) (in shares)         503,821      
Cashless exercise of common stock warrants (Note 13) 0       $ 5,000   (5,000)  
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) (in shares)         (244,130)      
Purchase of Convertible Preferred Stock and Common Stock by consolidated VIE Prosper Grantor Trust (Note 13) 69,000           (133,000) 202,000
Return of Convertible Preferred Stock from investor (Note 13) 152,000             152,000
Stock-based compensation expense 378,000           378,000  
Net income (loss) $ 6,381,000             6,381,000
Ending balance (in shares) at Jun. 30, 2026 79,935,949       84,869,054      
Ending balance at Jun. 30, 2026 $ (466,598,000)       $ 323,000 $ (23,417,000) $ 165,023,000 $ (608,527,000)
Ending balance (in shares) at Jun. 30, 2026           (5,177,235)